Regen BioPharma Inc (RGBP)

[cvinvestor]

WHY? The latest PR confirms previous PRs that HemaX protocols for a safety test that is needed to be completed before FDA approval is still under review. The protocols are under review. After they are approved we are looking at most likely 2-3 months before approval.

Let's stick to the facts of what we know. We know they've hired the Ichims and Caven and took out a loan to only cover a couple months salary. We are finally getting a steady diet of PRs with updates and seemingly good news. I don't see HemaX as the immediate factor or catalyst at the moment. HemaX right now is a future bonus as I believe NR2F6 target treatment is the key.

I will make another post with a couple quotes people may have missed that now seem to be coming to light.